Candida species are a major cause of infection worldwide. The species associated with infection vary with geographical location and with patient population. Infection with Candida tropicalis is particularly common in South America and Asia, and Candida parapsilosis infections are more common in the very young. Molecular methods for manipulating the genomes of these species are still lacking. We describe a simple and efficient CRISPR-based gene editing system that can be applied in the C. parapsilosis species group, including the sister species Candida orthopsilosis and Candida metapsilosis. We have also constructed a separate system for gene editing in C. tropicalis.
KEYWORDS: CRISPR, Candida, genome editing
ABSTRACT
Many Candida species that cause infection have diploid genomes and do not undergo classical meiosis. The application of clustered regularly interspaced short palindromic repeat-Cas9 (CRISPR-Cas9) gene editing systems has therefore greatly facilitated the generation of gene disruptions and the introduction of specific polymorphisms. However, CRISPR methods are not yet available for all Candida species. We describe here an adaption of a previously developed CRISPR system in Candida parapsilosis that uses an autonomously replicating plasmid. Guide RNAs can be introduced in a single cloning step and are released by cleavage between a tRNA and a ribozyme. The plasmid also contains CAS9 and a selectable nourseothricin SAT1 marker. It can be used for markerless editing in C. parapsilosis, C. orthopsilosis, and C. metapsilosis. We also show that CRISPR can easily be used to introduce molecular barcodes and to reintroduce wild-type sequences into edited strains. Heterozygous mutations can be generated, either by careful selection of the distance between the polymorphism and the Cas9 cut site or by providing two different repair templates at the same time. In addition, we have constructed a different autonomously replicating plasmid for CRISPR-Cas9 editing in Candida tropicalis. We show that editing can easily be carried out in multiple C. tropicalis isolates. Nonhomologous end joining (NHEJ) repair occurs at a high level in C. metapsilosis and C. tropicalis.
IMPORTANCE Candida species are a major cause of infection worldwide. The species associated with infection vary with geographical location and with patient population. Infection with Candida tropicalis is particularly common in South America and Asia, and Candida parapsilosis infections are more common in the very young. Molecular methods for manipulating the genomes of these species are still lacking. We describe a simple and efficient CRISPR-based gene editing system that can be applied in the C. parapsilosis species group, including the sister species Candida orthopsilosis and Candida metapsilosis. We have also constructed a separate system for gene editing in C. tropicalis.
INTRODUCTION
Opportunistic yeast pathogens, including Candida species, cause a wide variety of infections, ranging from superficial to systemic, which can often be fatal (1). Infection of premature neonates, the elderly, and immunocompromised patients is particularly common (2). Extensive use of catheters, broad-spectrum antibiotics, and abdominal surgery also favors the spread of pathogenic yeasts from their normal commensal niches (2).
More than 30 Candida species are known to cause disease (3, 4). Although C. albicans is the most common cause of candidiasis, the emergence of non-albicans Candida species such as Candida dubliniensis, Candida glabrata, Candida krusei, Candida parapsilosis, and Candida tropicalis has increased over the past decades (5, 6), and Candida auris has recently been reported as an emerging multidrug-resistant species (7, 8). Many of the well characterized Candida species, including C. albicans, C. parapsilosis, and C. tropicalis, belong to the CUG-Ser1 clade, in which the CUG codon is translated as serine rather than leucine (9, 10). C. tropicalis is particularly prevalent in South America and Asia (4). Infections by members of the C. parapsilosis group, which includes Candida orthopsilosis and Candida metapsilosis, are most common in the very young and the very old (11).
C. albicans and C. tropicalis and the C. parapsilosis species complex have diploid genomes and do not undergo meiosis, which makes generating deletion strains a difficult process. Each allele needs to be targeted independently. Several gene deletion methods based on homologous recombination were developed for C. albicans, including sequential replacement of alleles with a recyclable marker (12, 13) or with different markers in an auxotrophic background (14). Some systems were adapted for use in C. parapsilosis (15–17) and C. tropicalis (18–21). Recently, counterselection against the mazF gene of Escherichia coli was used to make markerless disruptions in C. tropicalis (22). The recent discovery of haploid forms of C. albicans has enabled disruption strategies in this species that are not yet applicable in the others (23–25).
The advent of clustered regularly interspaced short palindromic repeat (CRISPR)-based gene editing tools has revolutionized studies in many Candida species, including C. albicans, C. glabrata, C. lusitaniae, and C. auris (7, 26–37). Various approaches have been used, including integrating CAS9 in the genome (see, e.g., reference 26) and transient expression of CAS9 (33) and providing Cas9 as part of an RNA-protein complex (36, 37). Some systems require cloning (see, e.g., reference 27), and some can be constructed using only PCR (see, e.g., references 32 and 33). Some introduce markers at the target site that can be subsequently removed (see, e.g., reference 32). We recently described a CRISPR-Cas9 system on a replicating plasmid that can be used for markerless gene editing in C. parapsilosis (29). The CAS9-containing plasmid is quickly lost in the absence of selection. The system has also been applied in C. orthopsilosis (38). Although the plasmid-based gene editing method is efficient, two cloning steps were required, which means that it was not readily applicable to large-scale efforts. Here, we adapted the plasmid system so that the guide RNA (gRNA) was able to be introduced in a single cloning step. The system can also be used for gene editing in C. orthopsilosis and C. metapsilosis. Furthermore, we made a new plasmid for CRISPR editing in C. tropicalis. We show that with careful guide design, CRISPR can be used to generate heterozygous variants.
RESULTS AND DISCUSSION
Modification of plasmid-based CRISPR-Cas9 gene editing in C. parapsilosis.
We first described a plasmid-based CRISPR-Cas9 editing system in C. parapsilosis in 2017 (29). The guide RNA is introduced between two ribozymes (Hammerhead and hepatitis delta virus [HDV] ribozymes) in a two-step cloning process and is released by self-cleavage of the ribozymes. Changing the guide RNA to target a new gene also requires changing bases in the Hammerhead ribozyme. Here, we replaced the Hammerhead ribozyme with a tRNAAla sequence from C. parapsilosis using a synthetic construct, based on systems described by Ng and Dean (39) (pCP-tRNA) (Fig. 1A). The gRNA is now introduced in a single step by designing two 20-base oligonucleotides with overhanging ends compatible with two SapI sites (Fig. 1B). The mature single guide RNA (sgRNA) molecule is released by cleaving after the tRNAAla by endogenous yeast RNase Z endonuclease and self-splicing before the HDV ribozyme (Fig. 1D). The plasmid expresses CAS9 and contains a selectable marker (nourseothricin resistance; Fig. 1A). Plasmid loss is induced after only two passages in the absence of selection (Fig. 1C). Gene editing is carried out in a single transformation step, by introducing the plasmid together with a repair template (RT). Repair templates (described in reference 29) are generated by overlapping PCR and include homology arms that are 50 and 34 bp upstream and downstream of the cut site, respectively. Fig. 1E shows editing of C. parapsilosis ADE2 (CpADE2) using pCP-tRNA by the introduction of two stop codons, using sgADE2-B as previously described by Lombardi et al. (29). Disruptions in ADE2 are easily detected because they accumulate a red/pink pigment on yeast extract-peptone-dextrose (YPD) media, due to a defect in adenine biosynthesis. Transformants were screened by PCR using one primer specific to the edited site followed by sequencing (see Table S2 at https://doi.org/10.6084/m9.figshare.7776842). The efficiency of editing is comparable to that seen with the original system (approximately 80%).
We next explored the possibility of introducing unique molecular barcodes at the edited site while retaining short repair templates. We targeted the gene CPAR2_101060 as proof of principle, using a repair template with 30 bp of homology arms flanking 11 bp containing stop codons in all open reading frames and a unique tag (Fig. 2A). PCR screening of 15 transformants showed that the barcode was incorporated into all 15 (Fig. 2A). The edited site was confirmed by sequencing. This approach will be useful in large-scale studies, as it results in the disruption of the gene regardless of the reading frame and can be used to specifically barcode each mutant strain for use in competition studies. We also showed that short (30-bp) regions can be used to drive homologous recombination in C. parapsilosis.
Nguyen et al. (32) showed that CRISPR-Cas9 can be used to reconstitute mutated strains in C. albicans by reintroducing the wild-type sequence at the native locus. In that study (32), the edited sequence included a new protospacer adjacent motif (PAM) site that was targeted with a common gRNA. To avoid adding even more sequences at the edited site, we instead selected a naturally occurring PAM site 36 bp upstream from the edited region (Fig. 2B). A synonymous single nucleotide polymorphism (SNP) (G1420C) was introduced into the repair template so that we could distinguish the reconstituted strain from the original wild-type strain (Fig. 2B). Among 9 sequenced transformants, 2 contained the reconstituted wild-type sequence, removing the stop codon and the barcode from both alleles and introducing the synonymous SNP (reconstituted allele REC101060; see Table S1 at https://doi.org/10.6084/m9.figshare.7776833). The remaining 7 all contained the synonymous SNP, but they also retained the edited region and barcode, possibly due to the lower efficiency of homologous recombination corresponding to increasing distance from the Cas9 cut site, as discussed below (40).
CRISPR-Cas9 gene editing in C. metapsilosis.
Zoppo et al. (38) showed that the original plasmid designed for CRISPR editing in C. parapsilosis can be used to edit genes in C. orthopsilosis, and the tRNA-based plasmid is also effective in this species (F. Morio, L. Lombardi, U. Binder, C. Logé, E. Robert, D. Graessle, M. Bodin, C. Lass-Flörl, G. Butler, P. Le Pape, unpublished data). We therefore tested the pCP-tRNA system in C. metapsilosis, the third member of the C. parapsilosis species group, by targeting CmADE2. Unlike C. parapsilosis, where heterozygosity levels are low, all C. metapsilosis isolates characterized to date descended from hybridization between two parental strains that differed by about 5% at the sequence level (41). The pCP-tRNA plasmid is easily introduced into C. metapsilosis SZMC8093, where it propagates without integration. Similarly to C. parapsilosis, nourseothricin resistance is quickly lost in the absence of selection (Fig. 3A). Cells transformed with a plasmid targeting CmADE2 and a repair template carrying 35 and 48 bp of upstream and downstream homology regions designed to introduce two stop codons were edited with 100% efficiency. All transformants were pink when replica plated on YPD and failed to grow on synthetic media in the absence of adenine (Fig. 3B, right plate). PCR analysis of 95 transformants (see Fig. S1 at https://doi.org/10.6084/m9.figshare.7776761) using a allele specific primer showed that 88 had the expected mutation; that result was confirmed by sequencing 6 representative transformants. Repair by homologous recombination therefore occurs at a high rate in C. metapsilosis when a suitable repair template is provided. Interestingly, in the absence of the repair template, most colonies were also pink and adenine auxotrophs. Sequencing of 12 transformants showed that a variety of nonhomologous end joining (NHEJ)-like repair events had occurred, including deletion of either 2 or 3 nucleotides and insertion of 1 nucleotide, resulting in either a frameshift or the deletion of one amino acid (Fig. 3D). This suggests that repair via NHEJ is common in C. metapsilosis (Fig. 3D). All the NHEJ repair events were identical in the two alleles, indicating that NHEJ may have occurred at one allele, followed by a homology-directed repair (HDR) event at the second allele.
Designing a plasmid for gene editing in C. tropicalis.
Some advantages of using a replicating plasmid-based gene editing system are that any gene can be edited in any isolate in a markerless way. Currently, there are few methods available for editing in Candida species other than C. albicans and the C. parapsilosis species group. We found that the pCP-tRNA plasmid failed to generate nourseothricin-resistant transformants of C. tropicalis. We therefore adapted constructs designed by Defosse et al. (42), who previously identified suitable promoters and terminators for use in C. tropicalis. We first replaced the GFP gene in pAYCU268 from Defosse et al. (42) with CAS9 from Vyas et al. (27), placing CAS9 under the control of the TEF1 promoter from Meyerozyma guilliermondii. pAYCU268 expresses SAT1 from the C. dubliniensis TEF1 promoter and is designed to integrate randomly into the C. tropicalis genome. We identified an autonomously replicating sequence (CaARS2) which is reported to promote replication in C. tropicalis (43, 44) and introduced it into the pAYCU268 backbone. Finally, a tRNA cassette similar to that in pCP-tRNA was synthesized and inserted into the plasmid, generating pCT-tRNA (Fig. 4A). Guide RNAs were then able to be cloned between the tRNA and a ribozyme and were expressed from an Ashbya gossypii TEF1 promoter, followed by the Saccharomyces cerevisiae CYC1 terminator. An important feature of this plasmid is that, apart from CaARS2, all the DNA parts can be changed thanks to the presence of specific restriction sites.
The pCT-tRNA plasmid containing a guide RNA targeted against CtADE2 was used to transform 5 different isolates of C. tropicalis, together with a repair template designed to introduce one stop codon in each frame (Fig. 4D; see also Fig. S3 at https://doi.org/10.6084/m9.figshare.7776824). The repair template has 60-bp homology arms flanking the cleavage site and was generated by overlapping PCR. Pink auxotrophs were observed following transformation of each isolate, in the presence or absence of repair template, with efficiency ranging from 88% to 100% (Fig. 4B) (Table 1). PCR screening and subsequent sequencing analysis of representative transformants obtained using the repair template confirmed the presence of the inserted stop codons (Fig. 4D and E). In the absence of the repair template, pink adenine auxotrophs resulted from the deletion of one base near the Cas9 cut site (Fig. 4B; see also Fig. S3A at https://doi.org/10.6084/m9.figshare.7776824) (Table 1). The same deletion was found in both alleles. NHEJ-like repair events, possibly followed by HDR, therefore occur at a high frequency in C. tropicalis. Just like pCP-tRNA, the pCT-tRNA plasmid is rapidly lost from transformants grown in the absence of selection (Fig. 4), thus minimizing the risk of Cas9 cutting at off-target sites.
TABLE 1.
Strain | Target gene | % edited transformantsa
|
|||
---|---|---|---|---|---|
−RT |
+RT |
||||
Expt 1 | Expt 2 | Expt 1 | Expt 2 | ||
C. parapsilosis | |||||
CLIB214 | CpADE2 | No colonies | No colonies | 75 | 80 |
CLIB214 | CPAR2_101060 | No colonies | ND | 100 | ND |
C. metapsilosis | |||||
SZMC8093 | CmADE2 | 100 | ND | 100 | ND |
C. tropicalis | |||||
DSM4959 (ct44) | CtADE2 | 100 | 94 | 63 | 50 |
CAS08-0047 (ct45) | CtADE2 | 92 | 100 | 100 | 100 |
CAS08-0093 (ct46) | CtADE2 | 97 | 94 | 85 | 71 |
CAS08-0098 (ct47) | CtADE2 | 92 | 91 | 77 | 88 |
CAS08-0102 (ct48) | CtADE2 | 88 | 95 | 95 | 91 |
Data represent mutation efficiencies determined in one or two experiments. The mutation efficiency of ADE2 was calculated based on color and inability to grow in the absence of adenine. In the case of CPAR2_101060, the mutation efficiency was calculated based on PCR screening. RT, repair template; ND, not determined.
Using CRISPR to introduce heterozygous mutations.
One of the problems with CRISPR editing of diploid genomes is that it tends to be an all-or-nothing affair—either both alleles are edited or neither allele is. This can be a problem with essential genes, where editing both alleles would be lethal. Vyas et al. (26) approached this problem by generating temperature-sensitive alleles in C. albicans. However, Paquet and colleagues (40) recently described how the design of the repair template can be used to introduce mutations into just one allele in the genome of human cells. They showed that there is an inverse relationship between the efficiency of incorporation of a desired SNP and its distance from the Cas9-induced double-strand break. This can be exploited to push the editing system toward the introduction of mutations at one allele only. Alternatively, cells transformed with a mixture of two different repair templates can incorporate a different template at each allele (40). We tested if the same approaches are effective in C. parapsilosis by targeting the (nonessential) CPAR2_101060 gene.
Both strategies were used. In strategy 1, C. parapsilosis CLIB214 was transformed with a plasmid targeting CPAR2_101060 and with one of two repair templates. Both repair templates carry three base substitutions (GGG>ATC) that disrupt the PAM and that introduce a Gly154Ile amino acid change. In addition, one repair template contains one synonymous SNP (C>G) 10 bp upstream from the Cas9 cut site, and the second contains a different synonymous SNP (T>C) 19 bp upstream from the cut site (Fig. 5A; RTs Het_LL1 and Het_LL2, respectively). All the transformants obtained with either repair template that were tested by PCR contained the ATC amino acid change that also disrupts the PAM (Fig. 5A). Seven transformants obtained with the first repair template (Het_LL1) were all homozygous (either C or G) at the position 10 bp upstream from the cut site (Fig. 5A, upper panel). Using the second repair template (Het_LL2), 2 of 6 transformants tested were homozygous for the wild-type nucleotide, 3 incorporated C at both alleles, and 1 was heterozygous, with T at one allele and C at the second (Fig. 5A, lower panel). Increasing the mutation-to-cut site distance can therefore increase the chances of obtaining heterozygous substitutions in C. parapsilosis. It is probably necessary to disrupt the PAM site or the protospacer when using this strategy to prevent repeated recutting by Cas9.
In strategy 2, two repair templates (mixHet_1 and mixHet_2; Fig. 5B) were supplied simultaneously. Both were designed to introduce synonymous SNPs that disrupt either the PAM or the protospacer. One repair template also contained a stop codon immediately upstream of the PAM. Incorporation of one repair template at one allele and the other at the second allele should generate a functional heterozygote, in which one allele has a stop codon and one does not. PCR screening showed that one repair template or other was incorporated into 14 of 16 transformants tested (Fig. 5B). For two colonies, PCR and sequence analysis showed that both repair templates were incorporated, with a stop codon introduced at only one allele (Fig. 5B). The presence of the synonymous SNPs at both alleles indicated that homology-directed repair had occurred at both, with one repair using repair template 1 and the other repair using template 2. Two different strategies can therefore be used in combination with the pCP-tRNA plasmid to introduce heterozygous mutations.
Conclusion.
The pCP/CT-tRNA systems can be used for CRISPR-Cas9-mediated gene editing in all three members of the C. parapsilosis sensu lato complex, and in C. tropicalis. CRISPR editing can also be used to reconstitute wild-type alleles and to generate heterozygous mutations.
MATERIALS AND METHODS
Strains and media.
All C. parapsilosis, C. metapsilosis, and C. tropicalis strains used in this study (see Table S1 at https://doi.org/10.6084/m9.figshare.7776833) were grown in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) or on YPD plates (YPD plus 2% agar) at 30°C. Transformants were selected on YPD agar supplemented with 200 μg/ml nourseothricin (Werner Bioagents, Jena, Germany). Auxotrophies were confirmed by growing mutant strains on synthetic complete (SC) dropout media (0.19% yeast nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate, 2% glucose, 0.075% amino acid dropout mix, 2% agar). All the plasmids used in this study (see Table S3 at https://doi.org/10.6084/m9.figshare.7776845) were propagated in Escherichia coli DH5α cells (NEB, United Kingdom) by growing cells in LB media without NaCl (Formedium) supplemented with 100 μg/ml ampicillin (Sigma).
Construction of the pCP-tRNA series plasmids.
The synthetic construct GAPDHp-tRNA-SapI-HDV (Eurofins MWG; see Fig. S2 at https://doi.org/10.6084/m9.figshare.7776818) was designed to include the C. parapsilosis glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (GAPDH) (CPAR2_808670) promoter, a C. parapsilosis tRNAAla sequence, two tandem SapI/BspQI sites for the cloning of the guide, a hepatitis delta virus (HDV) ribozyme, and the GAPDH terminator. The cassette was cloned by Gibson assembly (primers are listed in Table S2 at https://doi.org/10.6084/m9.figshare.7776842) into NruI-digested pSAT3 plasmid, which differs from the published pSAT1 plasmid (29) only in that it does not contain any SapI/BspQI sites. The guide RNA was generated by annealing of two 23-bp oligonucleotides carrying appropriate overhanging ends and was cloned into the SapI-digested pCP-tRNA plasmid (see Table S2 at https://doi.org/10.6084/m9.figshare.7776842 and Table S3 at https://doi.org/10.6084/m9.figshare.7776845).
Construction of pCT-tRNA plasmids.
pAYCU268, from Defosse et al. (42), was used as a starting vector. The green fluorescent protein gene (GFP) was replaced with CAS9 from pV1326 (27) by Gibson assembly using primers jpGA_pAYCU268.fw and GA_pAYCU.CAS9.rv to amplify the backbone and primers jpGA_CAS9.1326.fw and pGA_Cas9.1326.rv to amplify CAS9, producing the plasmid GA_pAYCU.CAS9.1326. CaARS2 (43) was amplified using V3_GA.CaARS2.1326.fw and V3_GA.CaARS2.1326.rv and was introduced into the backbone amplified with the primers GA_pAYCUCAS9.1326.fw and GA_pAYCUCAS9.1326.rv by Gibson assembly. A SapI site in the plasmid backbone was removed in this step. A synthetic construct (Eurofins MWG; see Fig. S2 at https://doi.org/10.6084/m9.figshare.7776818) was designed as described for pCP-tRNA, except that expression of the sgRNA was driven from the A. gossypii TEF1 promoter and the CYC1 terminator from S. cerevisiae. The AgeI and SpeI restriction sites flanking the cassette were used for cloning into doubly digested GA_pAYCUCAS9.1326.ARS vector. C. tropicalis guide RNAs were designed using CHOPCHOP v2 (45, 46).
Transformation of Candida strains.
C. parapsilosis CLIB214 and C. metapsilosis SZMC8093 strains were transformed using the lithium acetate method as described in reference 29, with minor modifications. Each repair template was generated by primer extension of overlapping oligonucleotides (see Table S1 at https://doi.org/10.6084/m9.figshare.7776833 and Table S2 at https://doi.org/10.6084/m9.figshare.7776842), and 25 μl of unpurified product was used to transform yeast cells. Transformation of C. tropicalis strains was performed by using a modified electroporation protocol (12, 47, 48). C. tropicalis cells were grown to an A600 of 5 to 10 and then resuspended in 0.1 M lithium acetate–10 mM Tris-HCl (pH 8.0)–1 mM EDTA–10 mM dithiothreitol (DTT) and incubated at room temperature for 1 h. Cells were washed twice with ice-cold water and once in 1 M ice-cold sorbitol. The sorbitol wash was decanted, and cells were resuspended in the remaining liquid. Approximately 40 to 50 μl of cells was used per transformation, with 5 μg of plasmid together with 5 μg of purified repair template. Cells and DNA were electroporated at 1.8 kV by using a Bio-Rad Pulser XCell Electroporator and immediately resuspended in 1 ml of cold 1 M sorbitol. Cells were subsequently resuspended in 1 ml of YPD and allowed to recover for 4 h at 30°C before plating was performed on selective media (YPD plus 200 μg/ml nourseothricin). Nourseothricin-resistant transformants were patched onto YPD (and SC medium lacking adenine where indicated) and screened by colony PCR. The mutation efficiency was calculated as follows: (edited transformants on the plate) × 100/(total number of transformants on the plate). Representative mutants were sequenced by Sanger sequencing (Eurofins MWG). Loss of the plasmid was induced by patching transformants onto YPD agar without selection and repatching every 48 h until they no longer grew on YPD agar plates containing 200 μg/ml nourseothricin.
ACKNOWLEDGMENTS
We are grateful to N. Papon from Université Bretagne-Loire for the gift of plasmids.
This work was supported by awards from Science Foundation Ireland (12/IA/1343; https://www.sfi.ie) and the European Union’s Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. H2020-MSCA-ITN-2014-642095.
REFERENCES
- 1.Kullberg BJ, Arendrup MC. 2015. Invasive candidiasis. N Engl J Med 373:1445–1456. doi: 10.1056/NEJMra1315399. [DOI] [PubMed] [Google Scholar]
- 2.Turner SA, Butler G. 2014. The Candida pathogenic species complex. Cold Spring Harb Perspect Med 4:a019778. doi: 10.1101/cshperspect.a019778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gabaldón T, Naranjo-Ortíz MA, Marcet-Houben M. 2016. Evolutionary genomics of yeast pathogens in the Saccharomycotina. FEMS Yeast Res 16:fow064. doi: 10.1093/femsyr/fow064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kurtzman C, Fell JW, Boekhout T. 2011. The yeasts: a taxonomic study. Elsevier, Philadelphia, PA. [Google Scholar]
- 5.Pfaller MA, Pappas PG, Wingard JR. 2006. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 43:S3–S14. doi: 10.1086/504490. [DOI] [Google Scholar]
- 6.da Matta DA, Souza ACR, Colombo AL. 2017. Revisiting species distribution and antifungal susceptibility of Candida bloodstream isolates from Latin American medical centers. J Fungi (Basel) 3:E24. doi: 10.3390/jof3020024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Geddes-McAlister J, Shapiro RS. 2019. New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics. Ann N Y Acad Sci 1435:57–78. doi: 10.1111/nyas.13739. [DOI] [PubMed] [Google Scholar]
- 8.Sekyere JO, Asante J. 2018. Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics. Future Microbiol 13:241–262. doi: 10.2217/fmb-2017-0172. [DOI] [PubMed] [Google Scholar]
- 9.Riley R, Haridas S, Wolfe KH, Lopes MR, Hittinger CT, Göker M, Salamov AA, Wisecaver JH, Long TM, Calvey CH, Aerts AL, Barry KW, Choi C, Clum A, Coughlan AY, Deshpande S, Douglass AP, Hanson SJ, Klenk H-P, LaButti KM, Lapidus A, Lindquist EA, Lipzen AM, Meier-Kolthoff JP, Ohm RA, Otillar RP, Pangilinan JL, Peng Y, Rokas A, Rosa CA, Scheuner C, Sibirny AA, Slot JC, Stielow JB, Sun H, Kurtzman CP, Blackwell M, Grigoriev IV, Jeffries TW. 2016. Comparative genomics of biotechnologically important yeasts. Proc Natl Acad Sci U S A 113:9882–9887. doi: 10.1073/pnas.1603941113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Santos MA, Tuite MF. 1995. The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids Res 23:1481–1486. doi: 10.1093/nar/23.9.1481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pammi M, Holland L, Butler G, Gacser A, Bliss JM. 2013. Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr Infect Dis J 32:e206–e216. doi: 10.1097/INF.0b013e3182863a1c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Reuss O, Vik A, Kolter R, Morschhäuser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119–127. doi: 10.1016/j.gene.2004.06.021. [DOI] [PubMed] [Google Scholar]
- 13.Wilson RB, Davis D, Enloe BM, Mitchell AP. 2000. A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions. Yeast 16:65–70. doi:. [DOI] [PubMed] [Google Scholar]
- 14.Noble SM, Johnson AD. 2005. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot Cell 4:298–309. doi: 10.1128/EC.4.2.298-309.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ding C, Butler G. 2007. Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot Cell 6:1310–1319. doi: 10.1128/EC.00136-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gácser A, Trofa D, Schäfer W, Nosanchuk JD. 2007. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest 117:3049–3058. doi: 10.1172/JCI32294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Holland LM, Schröder MS, Turner SA, Taff H, Andes D, Grózer Z, Gácser A, Ames L, Haynes K, Higgins DG, Butler G. 2014. Comparative phenotypic analysis of the major fungal pathogens Candida parapsilosis and Candida albicans. PLoS Pathog 10:e1004365. doi: 10.1371/journal.ppat.1004365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lin C-J, Wu C-Y, Yu S-J, Chen Y-L. 2018. Protein kinase A governs growth and virulence in Candida tropicalis. Virulence 9:331–347. doi: 10.1080/21505594.2017.1414132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ko BS, Kim J, Kim JH. 2006. Production of xylitol from D-xylose by a xylitol dehydrogenase gene-disrupted mutant of Candida tropicalis. Appl Environ Microbiol 72:4207–4213. doi: 10.1128/AEM.02699-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang L, Chen X, Chen Z, Wang Z, Jiang S, Li L, Pötter M, Shen W, Fan Y. 2016. Development of an efficient genetic manipulation strategy for sequential gene disruption and expression of different heterologous GFP genes in Candida tropicalis. Appl Microbiol Biotechnol 100:9567–9580. doi: 10.1007/s00253-016-7762-7. [DOI] [PubMed] [Google Scholar]
- 21.Mancera E, Frazer C, Porman AM, Ruiz S, Johnson AD, Bennett RJ. Genetic modification of closely related Candida species. Front Microbiol, in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wang J, Peng J, Fan H, Xiu X, Xue L, Wang L, Su J, Yang X, Wang R. 2018. Development of mazF-based markerless genome editing system and metabolic pathway engineering in Candida tropicalis for producing long-chain dicarboxylic acids. J Ind Microbiol Biotechnol 45:971–981. doi: 10.1007/s10295-018-2074-9. [DOI] [PubMed] [Google Scholar]
- 23.Hickman MA, Zeng G, Forche A, Hirakawa MP, Abbey D, Harrison BD, Wang Y-M, Su C-H, Bennett RJ, Wang Y, Berman J. 2013. The “obligate diploid” Candida albicans forms mating-competent haploids. Nature 494:55–59. doi: 10.1038/nature11865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Segal ES, Gritsenko V, Levitan A, Yadav B, Dror N, Steenwyk JL, Silberberg Y, Mielich K, Rokas A, Gow NAR, Kunze R, Sharan R, Berman J. 2018. Gene essentiality analyzed by In Vivo transposon mutagenesis and machine learning in a stable haploid isolate of Candida albicans. mBio 9:e0204818. doi: 10.1128/mBio.02048-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gao J, Wang H, Li Z, Wong A-H, Wang Y-Z, Guo Y, Lin X, Zeng G, Liu H, Wang Y, Wang J. 2018. Candida albicans gains azole resistance by altering sphingolipid composition. Nat Commun 9:4495. doi: 10.1038/s41467-018-06944-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vyas VK, Barrasa MI, Fink GR. 2015. A CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv 1:e1500248. doi: 10.1126/sciadv.1500248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vyas VK, Bushkin GG, Bernstein DA, Getz MA, Sewastianik M, Barrasa MI, Bartel DP, Fink GR. 2018. New CRISPR mutagenesis strategies reveal variation in repair mechanisms among fungi. mSphere 3:e00154-18. doi: 10.1128/mSphere.00154-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Shapiro RS, Chavez A, Porter CBM, Hamblin M, Kaas CS, DiCarlo JE, Zeng G, Xu X, Revtovich AV, Kirienko NV, Wang Y, Church GM, Collins JJ. 2018. A CRISPR-Cas9-based gene drive platform for genetic interaction analysis in Candida albicans. Nat Microbiol 3:73–82. doi: 10.1038/s41564-017-0043-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lombardi L, Turner SA, Zhao F, Butler G. 2017. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9. Sci Rep 7:8051. doi: 10.1038/s41598-017-08500-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Evans BA, Pickerill ES, Vyas VK, Bernstein DA. 2018. CRISPR-mediated genome editing of the human fungal pathogen Candida albicans. J Vis Exp 14:e58764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Enkler L, Richer D, Marchand AL, Ferrandon D, Jossinet F. 2016. Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system. Sci Rep 6:35766. doi: 10.1038/srep35766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nguyen N, Quail MMF, Hernday AD. 2017. An efficient, rapid, and recyclable system for CRISPR-mediated genome editing in Candida albicans. mSphere 2:e00149-17. doi: 10.1128/mSphereDirect.00149-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Min K, Ichikawa Y, Woolford CA, Mitchell AP. 2016. Candida albicans gene deletion with a transient CRISPR-Cas9 system. mSphere 1:e00130-16. doi: 10.1128/mSphere.00130-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Huang MY, Mitchell AP. 2017. Marker recycling in Candida albicans through CRISPR-Cas9-induced marker excision. mSphere 2:e00050-17. doi: 10.1128/mSphere.00050-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Norton EL, Sherwood RK, Bennett RJ. 2017. Development of a CRISPR-Cas9 system for efficient genome editing of Candida lusitaniae. mSphere 2:e00217-17. doi: 10.1128/mSphere.00217-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Grahl N, Demers EG, Crocker AW, Hogan DA. 2017. Use of RNA-Protein complexes for genome editing in non- albicans Candida species. mSphere 2:e00218-17. doi: 10.1128/mSphere.00218-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rybak JM, Doorley LA, Nishimoto AT, Barker KS, Palmer GE, Rogers PD. 4 February 2019. Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris. Antimicrob Agents Chemother doi: 10.1128/AAC.00057-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Zoppo M, Lombardi L, Rizzato C, Lupetti A, Bottai D, Papp C, Gácser A, Tavanti A. 2018. CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells. Fungal Genet Biol 120:19–29. doi: 10.1016/j.fgb.2018.09.001. [DOI] [PubMed] [Google Scholar]
- 39.Ng H, Dean N. 2017. Dramatic improvement of CRISPR/Cas9 editing in Candida albicans by increased single guide RNA expression. mSphere 2:e00385-16. doi: 10.1128/mSphere.00385-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M. 2016. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533:125–129. doi: 10.1038/nature17664. [DOI] [PubMed] [Google Scholar]
- 41.Pryszcz LP, Németh T, Saus E, Ksiezopolska E, Hegedűsová E, Nosek J, Wolfe KH, Gacser A, Gabaldón T. 2015. The genomic aftermath of hybridization in the opportunistic pathogen Candida metapsilosis. PLoS Genet 11:e1005626. doi: 10.1371/journal.pgen.1005626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Defosse TA, Courdavault V, Coste AT, Clastre M, de Bernonville TD, Godon C, Vandeputte P, Lanoue A, Touzé A, Linder T, Droby S, Rosa CA, Sanglard D, d'Enfert C, Bouchara J-P, Giglioli-Guivarc'h N, Papon N. 2018. A standardized toolkit for genetic engineering of CTG clade yeasts. J Microbiol Methods 144:152–156. doi: 10.1016/j.mimet.2017.11.015. [DOI] [PubMed] [Google Scholar]
- 43.Cannon RD, Jenkinson HF, Shepherd MG. 1990. Isolation and nucleotide sequence of an autonomously replicating sequence (ARS) element functional in Candida albicans and Saccharomyces cerevisiae. Mol Gen Genet 221:210–218. [DOI] [PubMed] [Google Scholar]
- 44.Chatterjee G, Sankaranarayanan SR, Guin K, Thattikota Y, Padmanabhan S, Siddharthan R, Sanyal K. 2016. Repeat-associated fission yeast-like regional centromeres in the Ascomycetous budding yeast Candida tropicalis. PLoS Genet 12:e1005839. doi: 10.1371/journal.pgen.1005839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Labun K, Montague TG, Gagnon JA, Thyme SB, Valen E. 2016. CHOPCHOP v2: a Web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res 44:W272–W276. doi: 10.1093/nar/gkw398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Montague TG, Cruz JM, Gagnon JA, Church GM, Valen E. 2014. CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res 42:W401–W407. doi: 10.1093/nar/gku410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Porman AM, Alby K, Hirakawa MP, Bennett RJ. 2011. Discovery of a phenotypic switch regulating sexual mating in the opportunistic fungal pathogen Candida tropicalis. Proc Natl Acad Sci U S A 108:21158–21163. doi: 10.1073/pnas.1112076109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Reedy JL, Floyd AM, Heitman J. 2009. Mechanistic plasticity of sexual reproduction and meiosis in the Candida pathogenic species complex. Curr Biol 19:891–899. doi: 10.1016/j.cub.2009.04.058. [DOI] [PMC free article] [PubMed] [Google Scholar]